Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression as a Risk-Factor for SARS-CoV-2 Transmission in Concurrent Hospital Associated Outbreaks
Aidan M. Nikiforuk, Kevin S. Kuchinski, Katy Short, Susan Roman, Mike A. Irvine, Natalie Prystajecky, Agatha N. Jassem, David M. Patrick, Inna Sekirov
doi: https://doi.org/10.1101/2023.03.20.23287264
Aidan M. Nikiforuk
1British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
Kevin S. Kuchinski
1British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
Katy Short
3Fraser Health Authority, New Westminster, BC V3L 3C2, Canada
Susan Roman
3Fraser Health Authority, New Westminster, BC V3L 3C2, Canada
Mike A. Irvine
1British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
Natalie Prystajecky
1British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
Agatha N. Jassem
1British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
David M. Patrick
1British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
4School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
Inna Sekirov
1British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
Data Availability
The de-identified participant data that support the findings of this study are available from the British Columbia Ministry of Health. Restrictions apply to the availability of these data, which were used under agreement at the British Columbia Center for Disease Control for this study.
Posted March 21, 2023.
Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression as a Risk-Factor for SARS-CoV-2 Transmission in Concurrent Hospital Associated Outbreaks
Aidan M. Nikiforuk, Kevin S. Kuchinski, Katy Short, Susan Roman, Mike A. Irvine, Natalie Prystajecky, Agatha N. Jassem, David M. Patrick, Inna Sekirov
medRxiv 2023.03.20.23287264; doi: https://doi.org/10.1101/2023.03.20.23287264
Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression as a Risk-Factor for SARS-CoV-2 Transmission in Concurrent Hospital Associated Outbreaks
Aidan M. Nikiforuk, Kevin S. Kuchinski, Katy Short, Susan Roman, Mike A. Irvine, Natalie Prystajecky, Agatha N. Jassem, David M. Patrick, Inna Sekirov
medRxiv 2023.03.20.23287264; doi: https://doi.org/10.1101/2023.03.20.23287264
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12806)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)